Catecholamine dysfunction in attention-deficit/hyperactivity disorder an update

Journal of Clinical Psychopharmacology

Volumn 28, Issue 3 SUPPL. 2, 2008, Pages

  Prince, Jefferson ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL STIMULANT AGENT; DOPAMINE; METHYLPHENIDATE; NORADRENALIN;

ATTENTION; ATTENTION DEFICIT DISORDER; CHILD; CORPUS STRIATUM; DRUG EFFECT; FRONTAL LOBE; HUMAN; METABOLISM; MOTOR ACTIVITY; NERVE CELL INHIBITION; NERVE CELL NETWORK; PATHOPHYSIOLOGY; PHYSIOLOGY; PREFRONTAL CORTEX; REVIEW; SYNAPTIC TRANSMISSION;

ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CORPUS STRIATUM; DOPAMINE; FRONTAL LOBE; HUMANS; METHYLPHENIDATE; MOTOR ACTIVITY; NERVE NET; NEURAL INHIBITION; NOREPINEPHRINE; PREFRONTAL CORTEX; SYNAPTIC TRANSMISSION;

EID: 52049126864     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e318174f92a     Document Type: Review

References (65)

1. Murphy KR, Barkley RA. Parents of children with attention-deficit/ hyperactivity disorder: psychological and attentional impairment. Am J Orthopsychiatry. 1996;66:93-102. (Pubitemid 126500934)
2. Kessler RC, Adler L, Ames M, et al. The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers. J Occup Environ Med. 2005;47:565-572. (Pubitemid 40847440)
3. Faraone SV, Biederman J. What is the prevalence of adult ADHD? Results of a population screen of 966 adults. J Atten Disord. 2005;9:384-391. (Pubitemid 41608110)
4. Sprich S, Biederman J, Crawford MH, et al. Adoptive and biological families of children and adolescents with ADHD. J Am Acad Child Adolesc Psychiatry. 2000;39:1432-1437.
5. Faraone SV, Doyle AE. The nature and heritability of attention-deficit/ hyperactivity disorder. Child Adolesc Psychiatr Clin N Am. 2001;10:299-316. (Pubitemid 32416828)
6. Faraone SV, Doyle AE, Mick E, et al. Meta-analysis of the association between the 7-repeat allele of the dopamine D (4) receptor gene and attention deficit hyperactivity disorder. Am J Psychiatry. 2001;158:1052-1057. (Pubitemid 32623108)
7. Faraone SV, Perlis RH, Doyle AE, et al. Molecular genetics of attentiondeficit/hyperactivity disorder. Biol Psychiatry. 2005;57:1313-1323.
8. Bellgrove MA, Hawi Z, Gill M, et al. The cognitive genetics of attention deficit hyperactivity disorder (ADHD): sustained attention as a candidate phenotype. Cortex. 2006;42(6):838-845. (Pubitemid 46768738)
9. McGough JJ. Attention-deficit/hyperactivity disorder pharmacogenomics. Biol Psychiatry. 2005;57(11):1367-1373. (Pubitemid 40798556)
10. Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet. 2005;366:237-248. (Pubitemid 40981053)
11. Giedd JN, Blumenthal J, Molloy E, et al. Brain imaging of attention deficit/hyperactivity disorder. Ann N Y Acad Sci. 2001;931:33-49. (Pubitemid 32612780)
12. Arnsten AF, Li BM. Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol Psychiatry. 2005;57:1377-1384. (Pubitemid 40798558)
13. Zametkin AJ, Rapoport JL. Neurobiology of attention deficit disorder with hyperactivity: where have we come in 50 years? J Am Acad Child Adolesc Psychiatry. 1987;26:676-686. (Pubitemid 18016148)
14. Erratum in: J Am Acad Child Adolesc Psychiatry. 1988;27:388.
15. Sagvolden T, Johanson EB, Aase H, et al. A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes. Behav Brain Sci. 2005;28:397-419; discussion 419-468. (Pubitemid 41440193)
16. Burruss JW, Hurley RA, Taber KH, et al. Functional neuroanatomy of the frontal lobe circuits. Radiology. 2000;214:227-230. (Pubitemid 30019897)
17. Duffy JD, Campbell JJ 3rd. The regional prefrontal syndromes: a theoretical and clinical overview. J Neuropsychiatry Clin Neurosci. 1994;6:379-387. (Pubitemid 24344858)
18. Mega MS, Cummings JL. Frontal-subcortical circuits and neuropsychiatric disorders. J Neuropsychiatry Clin Neurosci. 1994;6:358-370. (Pubitemid 24344856)
19. Callicott JH, Matlay VS, Bertolino A, et al. Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. Cereb Cortex. 1999;9:20-26. (Pubitemid 29062016)
20. Bush G, Vogt BA, Holmes J, et al. Dorsal anterior cingulate cortex: a role in reward-based decision making. Proc Natl Acad Sci U S A. 2002;99:523-528. (Pubitemid 34060394)
21. Paus T, Petrides M, Evans AC, et al. Role of the human anterior cingulate cortex in the control of oculomotor, manual, and speech responses: a positron emission tomography study. J Neurophysiol. 1993;70:453-469. (Pubitemid 23239179)
22. Badgaiyan RD, Posner MI. Mapping the cingulate cortex in response selection and monitoring. Neuroimage. 1998;7:255-260. (Pubitemid 28372795)
23. Turken AU, Swick D. Response selection in the human anterior cingulate cortex. Nat Neurosci. 1999;2:920-924. (Pubitemid 30602607)
24. Carter CS, Braver TS, Barch DM, et al. Anterior cingulate cortex, error detection, and the online monitoring of performance. Science. 1998;280:747-749. (Pubitemid 28243351)
25. Biederman J, Spencer T. Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol Psychiatry. 1999;46:1234-1242. (Pubitemid 30114440)
26. Brozoski TJ, Brown RM, Rosvold HE, et al. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science. 1979;205:929-931.
27. Jaber M, Robinson SW, Missale C, et al. Dopamine receptors and brain function. Neuropharmacology. 1996;35:1503-1519. (Pubitemid 27026480)
28. Arnsten AF, Murphy B, Merchant K. The selective dopamine D4 receptor antagonist, PNU-101387G, prevents stress-induced cognitive deficits in monkeys. Neuropsychopharmacology. 2000;23:405-410.
29. Van Tol HH, Bunzow JR, Guan HC, et al. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature. 1991;350:610-614. (Pubitemid 21912282)
30. Wang X, Zhong P, Yan Z, et al. Dopamine D4 receptors modulate GABAergic signaling in pyramidal neurons of prefrontal cortex. J Neurosci. 2002;22:9185-9193. (Pubitemid 35356161)
31. Madras BK, Miller GM, Fischman AJ. The dopamine transporter and attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005;57:1397-1409. (Pubitemid 40798561)
32. Arnsten AF. Stimulants: therapeutic actions in ADHD. Neuropsychopharmacology. 2006;31(11):2376-2383. (Pubitemid 44607054)
33. MacDonald E, Kobilka BK, Scheinin M. Gene targeting-homing in on alpha 2-adrenoceptor-subtype function. Trends Pharmacol Sci. 1997;18:211-219. (Pubitemid 27283651)
34. Sesack SR, Hawrylak VA, Matus C, et al. Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J Neurosci. 1998;18:2697-2708. (Pubitemid 28141815)
35. De La Garza R 2nd, Madras BK. [(3) H]PNU-101958, a D (4) dopamine receptor probe, accumulates in prefrontal cortex and hippocampus of non-human primate brain. Synapse. 2000;37:232-244. (Pubitemid 30604927)
36. Mazei MS, Pluto CP, Kirkbride B, et al. Effects of catecholamine uptake blockers in the caudate-putamen and subregions of the medial prefrontal cortex of the rat. Brain Res. 2002;936:58-67. (Pubitemid 34461933)
37. Ingram SL, Prasad BM, Amara SG. Dopamine transporter-mediated conductances increase excitability of midbrain dopamine neurons. Nat Neurosci. 2002;5:971-978.
38. Bilder RM, Volavka J, Lachman HM, et al. The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology. 2004;29:1943-1961. (Pubitemid 39486546)
39. Spencer TJ, Biederman J, Madras BK, et al. In vivo neuroreceptor imaging in attention-deficit/hyperactivity disorder: a focus on the dopamine transporter. Biol Psychiatry. 2005;57:1293-1300. (Pubitemid 40798548)
40. Faraone SV, Biederman J. Neurobiology of attention-deficit hyperactivity disorder. Biol Psychiatry. 1998;44:951-958. (Pubitemid 28545223)
41. Valera EM, Faraone SV, Murray KE, et al. Meta-analysis of structural imaging findings in attention-deficit/hyperactivity disorder. Biol Psychiatry. 2007;61(12):1361-1369. (Pubitemid 46855763)
42. Castellanos FX, Sharp WS, Gottesman RF, et al. Anatomic brain abnormalities in monozygotic twins discordant for attention deficit hyperactivity disorder. Am J Psychiatry. 2003;160:1693-1696. (Pubitemid 41079559)
43. Bush G, Frazier JA, Rauch SL, et al. Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop. Biol Psychiatry. 1999;45:1542-1552. (Pubitemid 29292830)
44. Barkley RA, Grodzinsky G, DuPaul GJ. Frontal lobe functions in attention deficit disorder with and without hyperactivity: a review and research report. J Abnorm Child Psychol. 1992;20:163-188.
45. Shaw P, Lerch J, Greenstein D, et al. Longitudinal mapping of cortical thickness and clinical outcome in children and adolescents with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2006;63:540-549.
46. Dickstein SG, Bannon K, Castellanos FX, et al. The neural correlates of attention deficit hyperactivity disorder: an ALE meta-analysis. J Child Psychol Psychiatry. 2006;47(10):1051-1062. (Pubitemid 44642434)
47. Castellanos FX, Margulies DS, Kelly C, et al. Cingulate-precuneus interactions: a new locus of dysfunction in adult attention-deficit/ hyperactivity disorder. Biol Psychiatry. 2008;63(3):332-337.
48. Pliszka SR. The neuropsychopharmacology of attention-deficit/ hyperactivity disorder. Biol Psychiatry. 2005;57:1385-1390. (Pubitemid 40798559)
49. Bobb AJ, Addington AM, Sidransky E, et al. Support for association between ADHD and two candidate genes: NET1 and DRD1. Am J Med Genet B Neuropsychiatr Genet. 2005;134:67-72. (Pubitemid 40411112)
50. Volkow ND, Wang GJ, Newcorn J, et al. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2007;64(8):932-940. (Pubitemid 47230617)
51. van Dyck CH, Quinlan DM, Cretella LM, et al. Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder. Am J Psychiatry. 2002;159(2):309-312. (Pubitemid 34126913)
52. Jucaite A, Fernell E, Halldin C, et al. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity. Biol Psychiatry. 2005;57(3):229-238. (Pubitemid 40187366)
53. Dougherty DD, Bonab AA, Spencer TJ, et al. Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet. 1999;354:2132-2133. (Pubitemid 30008900)
54. Krause KH, Dresel SH, Krause J, et al. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography. Neurosci Lett. 2000;285:107-110. (Pubitemid 30227631)
55. Spencer TJ, Biederman J, Madrass BK, et al. Further evidence of dopamine transporter dysregulation in ADHD: a controlled PET imaging study using altropane. Biol Psychiatry. 2007;62(9):1059-1061. (Pubitemid 47562362)
56. Bellgrove MA, Hawi Z, Kirley A, et al. Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder. Neuropsychopharmacology. 2005;30:2290-2297. (Pubitemid 41643982)
57. Ma CL, Arnsten AF, Li BM. Locomotor hyperactivity induced by blockade of prefrontal cortical alpha2-adrenoceptors in monkeys. Biol Psychiatry. 2005;57:192-195. (Pubitemid 40094721)
58. Levy F. Pharmacological and therapeutic directions in ADHD: Specificity in the PFC. Behav Brain Funct. 2008;4(1):12.
59. Berridge CW, Devilbiss DM, Andrzejewski ME, et al. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry. 2006;60(10):1111-1120. (Pubitemid 44647216)
60. Greydanus DE. Pharmacologic treatment of attention-deficit hyperactivity disorder. Indian J Pediatr. 2005;72:953-960. (Pubitemid 41754496)
61. Bymaster FP, Katner JS, Nelson DL, et al. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention-deficit/hyperactivity disorder. Neuropsychopharmacology. 2002;27(5):699-711. (Pubitemid 35335888)
62. Nigg JT. Neuropsychologic theory and findings in attention-deficit/ hyperactivity disorder: the state of the field and salient challenges for the coming decade. Biol Psychiatry. 2005;57:1424-1435. (Pubitemid 40798564)
63. Smoller JW, Biederman J, Arbeitman L, et al. Association Between the 5HT1B Receptor Gene (HTR1B) and the Inattentive Subtype of ADHD. Biol Psychiatry. 2006;59:460-467. (Pubitemid 43289227)
64. Mick E, Biederman J, Prince J, et al. Impact of low birth weight on attention-deficit hyperactivity disorder. J Dev Behav Pediatr. 2002;23:16-22. (Pubitemid 34213410)
65. Milberger S, Biederman J, Faraone SV, et al. ADHD is associated with early initiation of cigarette smoking in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1997;36:37-44. (Pubitemid 27024226)